Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-12-16 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 578,075
2019-11-20 Glazer Donald W. Director Gift −81,060 3,630,366
2019-11-18 Liang Howard CFO & Chief Strategy Officer Option exercise +25,000 $6.50 $163K 25,000
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −1,156 $191.80 $222K 23,844
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −2,311 $192.63 $445K 21,533
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −6,944 $193.60 $1.3M 14,589
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −8,156 $194.62 $1.6M 6,433
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −5,633 $195.57 $1.1M 800
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −200 $196.63 $39K 600
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −200 $197.55 $40K 400
2019-11-18 Liang Howard CFO & Chief Strategy Officer Sale −400 $198.93 $80K 0
2019-11-18 Liang Howard CFO & Chief Strategy Officer Option exercise · Stock Option (Right to Buy) −325,000 3,795,000
2019-11-18 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2019-11-18 Huang Jane CMO, Hematology Sale −200 $192.24 $38K 1,300
2019-11-18 Huang Jane CMO, Hematology Sale −500 $193.63 $97K 800
2019-11-18 Huang Jane CMO, Hematology Sale −605 $195.01 $118K 195
2019-11-18 Huang Jane CMO, Hematology Sale −95 $195.82 $19K 100
2019-11-18 Huang Jane CMO, Hematology Sale −100 $198.93 $20K 0
2019-11-18 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 597,575
2019-11-15 Wang Xiaodong Director Sale −1,496 $202.05 $302K 0

Page 97 of 99 · 1,972 trades